• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Isothermal Nucleic Acid Amplification Technologies Market 2012-2017: Molecular Diagnostics, Infectious Disease Testing, Blood Screening, Cancer Research, Rapid Testing - Product Image

Isothermal Nucleic Acid Amplification Technologies Market 2012-2017: Molecular Diagnostics, Infectious Disease Testing, Blood Screening, Cancer Research, Rapid Testing

  • Published: October 2012
  • Region: Global
  • 144 Pages
  • Markets and Markets

FEATURED COMPANIES

  • BIOHELIX
  • BIOMERIEUX
  • EIKEN CHEMICAL CO., LTD.
  • HOLOGIC GEN-PROBE
  • LUCIGEN
  • MERIDIAN BIOSCIENCE INC
  • MORE

“Isothermal Nucleic Acid Amplification Technologies (INAAT)” discloses the promising trends in Nucleic acid testing and their applications in molecular diagnostics and laboratory research on a global scale. The World Health Organization (WHO) proposes that, an ideal diagnostic test that is suitable for developing countries, should be Affordable, Sensitive, Specific and User-friendly (simple to perform in a few steps with minimal training), Robust and rapid (results available in minutes), Equipment free and Deliverable to the end user (ASSURED). Nucleic acid amplification tests targeting pathogen markers have high sensitivity and specificity, but generally fail to meet the ASSURED guidelines in terms of affordability, rapidity, and being equipment free. However, INAAT has recently attracted the scientific community due to their operation in single temperature and distinct features by meeting the ASSURED guidelines. With fine-tunings in the amplification methodology, a variety of INAAT types are discovered each being independent, driving the diagnostic platform towards Point-Of-Care (POC) testing at low resource settings.

This research report provides in-depth details READ MORE >

1 Introduction

1.1 Key Take-Aways

1.2 Report Scope

1.3 Research Methodology

1.4 Key Data Sources



2 Executive Summary



3 Isothermal Nucleic Acid Amplification Technologies (INAAT) – Technology Landscape Analysis

3.1 Technology Overview

3.2 INAAT Vs Conventional Methods – Competitive Advantages

3.3 Technology Value Chain Analysis

3.4 Comparative Analysis of INAAT Types

3.5 Applications

3.5.1 INAAT - Molecular Diagnostics

3.5.1.1. Infectious Disease Diagnostics

3.5.1.2. Blood Screening

3.5.2 INAAT - Research Applications

3.5.2.1 Laboratory Research

3.5.2.2 Cancer Research

3.6 Product/Technology Innovations - Applications



4 Technology Investment Potential

4.1 Investment Climate Assessment

4.1 Investor Network

4.1.1 Public Funding Bodies

4.1.2 Philanthropic Bodies

4.1.3 Private Investors & Venture Capital Firms

4.1.4 Insights on Current & Future Tech-Investment Trends

4.1.5 Some of The Funds & Investments on INAAT

4.2.1 Investment Opportunities

4.2.1.1 Evaluation of Technologies Available For Licensing & Acquisition For Stakeholders

4.2.2.2 Analysis of Potential Application Areas For Technology Investment Using OSE Grid

5 INAAT - Market Landscape Analysis

5.1 Market Segmentation

5.2 INAAT Market Share In Molecular Diagnostics (MDX)

5.3 Global Market Forecast

5.3.1 By Geography

5.3.2 By Applications

5.4 Market Dynamics

5.4.1 Drivers

5.4.2 Restraints

5.4.3 Challenges

5.4.4 Current & Emerging Opportunities

5.5 Demand Side Analysis

6 INAAT – Technology Adoption Potential & Development By Geography

6.1 Technology Adoption & Development – Key Findings

6.2 North America

6.3 Europe

6.4 ASIA

6.5 Rest Of The World

6.6 Regions With High Technology Adoption



7 Competitive Landscape

7.1 Mergers & Acquisitions (2007-2012)

7.2 Partnerships & Collaborations (2007-2012)

7.3 New Product Development Initiatives – 2012

7.3.1 List of New approved INAAT products – 2012

7.3.2 INAAT Products – In-Pipeline

7.3.3 Research Innovations

8 Patent Analysis And Research Trend (Publications) 2007-2012

8.1 Patent Landscape Analysis (2007-2012)

8.2 Research Landscape (2007-2012)



9 TECHNOLOGY ANALYSIS (USING AHP) & ROAD MAPPING



10 Analyst Insights & Recommendations

10.1 Strategic Recommendations For Technology & Business Management

10.2 Key Invitations & Opportunities



11 Company Profiles

11.1 BECTON, DICKINSON AND COMPANY (BD)

11.2 BIOHELIX

11.3 BIOMERIEUX

11.4 EIKEN CHEMICAL CO., LTD.

11.5 HOLOGIC GEN-PROBE

11.6 LUCIGEN

11.7 MERIDIAN BIOSCIENCE INC

11.8 NEW ENGLAND BIOLABS

11.9 NOVARTIS DIAGNOSTICS

11.1 NUGEN

11.11 QIAGEN

11.12 TWISTDX

11.13 USTAR BIOTECHNOLOGIES (HANGZHOU) LTD.



12 Appendix



13 Glossary

List of Tables:

Table 1 NIH funding details and estimation in infectious diseases during the Fiscal Year (FY) 2010 –2013
Table 2 NIH and CDC Total Funds Towards Infectious Diseases
Table 3 Gates Foundation Grants (1994 to 2009)
Table 4 Funds and Investments on INAAT
Table 5 Mergers and Acquisitions (2007-2012)
Table 6 Partnerships and Collaborations (2007-2012)
Table 7 List of new approved INAAT products
Table 8 INAAT products – In pipeline
Table 9 Key patents
Table 10 Current research in INAAT

List of FIGURES:

FIG 1 Market revenue forecast of INAAT in line with Molecular diagnostics
FIG 2 INAAT capability towards POCT
FIG 3 INAAT products currently available for infectious diseases
FIG 4 NIH and CDC Total Funds Towards Infectious Diseases
FIG 5 INAAT market share in molecular diagnostics (MDx)
FIG 6 Market Share (%) and Revenues ($ Million) By Region (2012)
FIG 7 Market Share (%) and Revenues ($ Million) By Region (2017)
FIG 8 Market Share (%) and Revenues ($ Million) By Applications (2012)
FIG 9 Market Share (%) and Revenues ($ Million) By Applications (2017)
FIG 10 No. of Patents Published Between The Years 2007-2012
FIG 11 Comparative Analysis of Papers Published For Individual Technology Between 2007-2012
FIG 12 Research Papers Published Between the Years (2007-2012)
FIG 13 Priority values for Level 0
FIG 14 Comparison of Technology based on Level 0 criteria
FIG 15 Ranking Values Received by the Technologies

- BECTON, DICKINSON AND COMPANY (BD)

- BIOHELIX

- BIOMERIEUX

- EIKEN CHEMICAL CO., LTD.

- HOLOGIC GEN-PROBE

- LUCIGEN

- MERIDIAN BIOSCIENCE INC

- NEW ENGLAND BIOLABS

- NOVARTIS DIAGNOSTICS

- NUGEN

- QIAGEN

- TWISTDX

- USTAR BIOTECHNOLOGIES (HANGZHOU) LTD.

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos